SCHEMBL6201294

SCHEMBL6201294

NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)CCC(=O)N4)cs2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.66
SMN1; SMN2 Q16637 4/20 0.66
POLB P06746 3/20 0.66
ALDH1A1 P00352 3/20 0.66
HTT P42858 1/20 0.66
NPC1 O15118 5/20 0.61
RAB9A P51151 5/20 0.61
MMP12 P39900 1/20 0.61
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
PIM1 P11309 1/20 0.46
PIM3 Q86V86 1/20 0.46
EIF4E P06730 1/20 0.45
SCN9A Q15858 1/20 0.44
KDM4E B2RXH2 4/20 0.44
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 2/20 0.42
TBXAS1 P24557 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197654 0.90 SMN1; SMN2 (0.64) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL8525270 0.85 SMN1; SMN2 (0.70) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL6196524 0.84 MAPT (0.61) MAPTSMN1; SMN2POLBALDH1A1HTT
Hydrochloric Acid SCHEMBL6202875 0.81 MAPT (0.64) MAPTSMN1; SMN2POLBALDH1A1HTT
Bromide SCHEMBL6201510 0.81 MAPT (0.64) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL3307683 0.81 KIF11 (0.61) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL5068409 0.80 MAPT (1.00) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL6196901 0.80 MAPT (0.64) MAPTSMN1; SMN2POLBALDH1A1HTT
Hydrochloric Acid SCHEMBL21799330 0.79 MAPT (0.97) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL8525368 0.79 SMN1; SMN2 (0.60) MAPTSMN1; SMN2POLBALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed